AF

Amalgamated Financial Portfolio holdings

AUM $12.6B
This Fund
S&P 500
This Quarter Est. Return
1 Year Est. Return
3 Year Est. Return
5 Year Est. Return
10 Year Est. Return
AUM
$12.6B
AUM Growth
Cap. Flow
Cap. Flow %
Top 10 Hldgs %
Holding
3,002
New
Increased
Reduced
Closed

Top Buys

1 +$709M
2 +$617M
3 +$371M
4
GOOGL icon
Alphabet (Google) Class A
GOOGL
+$223M
5
TSLA icon
Tesla
TSLA
+$208M

Top Sells

No sells this quarter

Sector Composition

1 Technology 24.52%
2 Financials 13.15%
3 Healthcare 13.05%
4 Consumer Discretionary 12.17%
5 Industrials 9.28%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
FRBA icon
2651
First Bank
FRBA
$365M
$27K ﹤0.01%
+1,884
FSBW icon
2652
FS Bancorp
FSBW
$302M
$27K ﹤0.01%
+863
PLRX icon
2653
Pliant Therapeutics
PLRX
$73.7M
$27K ﹤0.01%
+3,844
SGC icon
2654
Superior Group of Companies
SGC
$181M
$27K ﹤0.01%
+1,537
TK icon
2655
Teekay
TK
$1.16B
$27K ﹤0.01%
+8,398
JNCE
2656
DELISTED
Jounce Therapeutics, Inc. Common Stock
JNCE
$27K ﹤0.01%
+3,986
CIA icon
2657
Citizens
CIA
$265M
$26K ﹤0.01%
+6,036
CRMD icon
2658
CorMedix
CRMD
$620M
$26K ﹤0.01%
+4,747
FTCI icon
2659
FTC Solar
FTCI
$82.6M
$26K ﹤0.01%
+535
IMUX icon
2660
Immunic
IMUX
$145M
$26K ﹤0.01%
+2,264
KNTK icon
2661
Kinetik
KNTK
$3.49B
$26K ﹤0.01%
+812
MTRX icon
2662
Matrix Service
MTRX
$377M
$26K ﹤0.01%
+3,151
TEAD
2663
Teads Holding Co
TEAD
$89.5M
$26K ﹤0.01%
+2,462
OTLK icon
2664
Outlook Therapeutics
OTLK
$31.7M
$26K ﹤0.01%
+725
RBBN icon
2665
Ribbon Communications
RBBN
$469M
$26K ﹤0.01%
+8,506
RXST icon
2666
RxSight
RXST
$306M
$26K ﹤0.01%
+2,072
TLYS icon
2667
Tilly's
TLYS
$138M
$26K ﹤0.01%
+2,741
URGN icon
2668
UroGen Pharma
URGN
$1.13B
$26K ﹤0.01%
+2,960
CBAY
2669
DELISTED
Cymabay Therapeutics
CBAY
$26K ﹤0.01%
+8,381
EAR
2670
DELISTED
Eargo, Inc. Common Stock
EAR
$26K ﹤0.01%
+246
AMSC icon
2671
American Superconductor
AMSC
$2.39B
$25K ﹤0.01%
+3,339
BYRN icon
2672
Byrna Technologies
BYRN
$122M
$25K ﹤0.01%
+3,012
CTXR icon
2673
Citius Pharmaceuticals
CTXR
$19.5M
$25K ﹤0.01%
+549
CUE icon
2674
Cue Biopharma
CUE
$97.2M
$25K ﹤0.01%
+5,025
DRRX
2675
DELISTED
DURECT Corp
DRRX
$25K ﹤0.01%
+3,695